RedHill Biopharma Statistics Share Statistics RedHill Biopharma has 2.3M
shares outstanding. The number of shares has increased by -0.17%
in one year.
Shares Outstanding 2.3M Shares Change (YoY) -0.17% Shares Change (QoQ) -0.14% Owned by Institutions (%) 0.01% Shares Floating 2.28M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 24.54K, so 1.07% of the outstanding
shares have been sold short.
Short Interest 24.54K Short % of Shares Out 1.07% Short % of Float 1.2% Short Ratio (days to cover) 1.51
Valuation Ratios The PE ratio is -1.85 and the forward
PE ratio is null.
RedHill Biopharma's PEG ratio is
0.02.
PE Ratio -1.85 Forward PE n/a PS Ratio 1.9 Forward PS n/a PB Ratio -3.27 P/FCF Ratio -1.63 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for RedHill Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.54,
with a Debt / Equity ratio of -0.08.
Current Ratio 0.54 Quick Ratio 0.37 Debt / Equity -0.08 Debt / EBITDA -0.05 Debt / FCF -0.04 Interest Coverage -27.55
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $229.8K Profits Per Employee $-236.23K Employee Count 35 Asset Turnover 0.45 Inventory Turnover 0.87
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 4.17, so RedHill Biopharma's
price volatility has been higher than the market average.
Beta 4.17 52-Week Price Change n/a 50-Day Moving Average 1.83 200-Day Moving Average 4.15 Relative Strength Index (RSI) 32.08 Average Volume (20 Days) n/a
Income Statement In the last 12 months, RedHill Biopharma had revenue of 8.04M
and earned -8.27M
in profits. Earnings per share was -3.
Revenue 8.04M Gross Profit 4.85M Operating Income -14.61M Net Income -8.27M EBITDA -7.59M EBIT -8.21M Earnings Per Share (EPS) -3
Full Income Statement Balance Sheet The company has 4.62M in cash and 356K in
debt, giving a net cash position of 4.26M.
Cash & Cash Equivalents 4.62M Total Debt 356K Net Cash 4.26M Retained Earnings -414.8M Total Assets 18.04M Working Capital -10.31M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.37M
and capital expenditures -9K, giving a free cash flow of -9.38M.
Operating Cash Flow -9.37M Capital Expenditures -9K Free Cash Flow -9.38M FCF Per Share -3.81
Full Cash Flow Statement Margins Gross margin is 60.31%, with operating and profit margins of -181.69% and -102.8%.
Gross Margin 60.31% Operating Margin -181.69% Pretax Margin -102.8% Profit Margin -102.8% EBITDA Margin -94.42% EBIT Margin -181.69% FCF Margin -116.6%
Dividends & Yields RDHL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for RDHL.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 20, 2024. It was a
backward
split with a ratio of 1:25.
Last Split Date Aug 20, 2024 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -34.6 Piotroski F-Score 2
